PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates

Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a therapeutic target for the reduction of low-density lipoprotein cholesterol (LDL-C). PCSK9 increases the degradation of the LDL receptor, resulting in high LDL-C in individuals with high PCSK9 activity. Here, we show that two loc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lindholm, Marie W, Elmén, Joacim, Fisker, Niels, Hansen, Henrik F, Persson, Robert, Møller, Marianne R, Rosenbohm, Christoph, Ørum, Henrik, Straarup, Ellen M, Koch, Troels
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2012
Subjects:	Original Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3277239/ https://ncbi.nlm.nih.gov/pubmed/22108858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.260
Tags:	Add Tag No Tags, Be the first to tag this record!

PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates

Similar Items